Artelo Biosciences, Inc. (ARTL)
1.425
-0.04
(-3.06%)
USD |
NASDAQ |
Feb 09, 16:00
1.425
0.00 (0.00%)
After-Hours: 18:13
Artelo Biosciences Total Assets (Quarterly) : 4.267M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 4.852B |
| Savara, Inc. | 140.92M |
| BioMarin Pharmaceutical, Inc. | 7.615B |
| Imunon, Inc. | 8.988M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.90M |
| Shareholders Equity (Quarterly) | -0.633M |
| Debt to Equity Ratio | -1.507 |
| Current Ratio | 0.3759 |
| Net Debt Paydown Yield | -5.19% |